Dxplora diagnostics development and manufacturing coordination

How to Evaluate a PCR Assay Development and Manufacturing Partner

Use a practical technical and operational checklist to compare PCR development and manufacturing partners before project transfer.

How to Evaluate a PCR Assay Development and Manufacturing Partner

Key takeaways

  • Evaluate technical fit, documentation, manufacturing pathway, communication, and change control separately.
  • Ask what work is performed directly and what is coordinated through another facility.
  • A credible partner defines assumptions, exclusions, decision points, and evidence rather than promising a result in advance.
  • Choose the partner for the next stage while confirming a plausible path to repeat supply.

A PCR development and manufacturing partner should be evaluated on more than a capabilities list. The right partner understands the current assay stage, explains what information is missing, proposes a controlled sequence of work, documents material and decisions, and shows how a successful evaluation could move toward repeat supply.

Confirm the exact technical scope

Ask whether the partner supports primer-probe review, chemistry selection, multiplex balancing, controls, liquid configuration, lyophilization, filling, packaging, evaluation quantities, pilot production, and repeat manufacturing. Do not assume that the word development includes every one of these activities.

Understand where work is performed

Some organizations perform all work in one facility; others use qualified specialist partners. Either model can work when responsibilities, material movement, records, communication, and quality oversight are explicit. The important question is not whether a network exists but whether it is controlled and transparent.

Review the proposed development logic

A strong proposal identifies inputs, assumptions, experiments, outputs, review points, and what happens when criteria are not met. Be cautious when a proposal jumps directly to a large manufacturing quantity or treats an undefined assay as a fixed product.

Examine documentation and change handling

Discuss specifications, batch records, lot identifiers, release information, deviations, retained knowledge, raw data access, oligonucleotide changes, supplier substitutions, and communication before changes. Documentation should support continuity rather than appear only after a problem.

Test communication before committing

Technical projects need a named owner, review cadence, decision route, and realistic response expectations. Notice whether questions receive specific answers, whether limitations are stated, and whether the team distinguishes development data from claims the evidence cannot support.

Check the path beyond the first lot

An evaluation partner should be able to explain how the chosen materials, vessel, packaging, release approach, and forecast could transition into pilot and repeat production. That does not require a premature long-term commitment, but it prevents an attractive prototype from reaching another dead end.

Frequently asked questions

Should one partner perform development and manufacturing?

It can reduce handoffs, but a coordinated specialist network can also work well when technical ownership, records, and transfer controls are clear.

What should be included in a PCR development proposal?

Inputs, scope, assumptions, experiments, material quantities, outputs, acceptance or review points, exclusions, timing dependencies, and the next-stage pathway.

How can a startup compare partners fairly?

Give each partner the same structured brief and compare technical interpretation, gaps identified, evidence plan, transparency, and continuity rather than price alone.

Primary references